These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2648967)

  • 41. Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic complex ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC Study Group.
    Hohnloser SH; Meinertz T; Stubbs P; Crijns HJ; Blanc JJ; Rizzon P; Cheuvart B
    Circulation; 1995 Sep; 92(6):1517-25. PubMed ID: 7664435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term sotalol therapy in patients with arrhythmias.
    Simon A; Berman E
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):547-56. PubMed ID: 385638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias.
    Anastasiou-Nana MI; Gilbert EM; Miller RH; Singh S; Freedman RA; Keefe DL; Saksena S; MacNeil DJ; Anderson JL
    Am J Cardiol; 1991 Mar; 67(6):511-6. PubMed ID: 1705386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy of sotalol in suppressing ventricular ectopic beats.
    Myburgh DP; Goldman aP; Cartoon J; Schamroth JM
    S Afr Med J; 1979 Aug; 56(8):295-8. PubMed ID: 399099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.
    Singh BN; Deedwania P; Nademanee K; Ward A; Sorkin EM
    Drugs; 1987 Sep; 34(3):311-49. PubMed ID: 3315621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of acute cardiac arrhythmias using adrenergic beta blockaders. Experience with sotalol].
    Martín Jadraque L; Liste Jiménez D; González Maqueda I; Del Rio Bustos A
    Rev Esp Cardiol; 1975; 38(2):153-62. PubMed ID: 1135483
    [No Abstract]   [Full Text] [Related]  

  • 47. [Prevalence of atrial arrhythmia in 48 hypertensive patients: research of predictive criteria].
    Breuillac JC; Babuty D; Charniot JC; Fauchier L; Richard MP; Cosnay P; Fauchier JP
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1123-6. PubMed ID: 1482244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Syncope during potassium depletion (author's transl)].
    Gola E; Arosio G; Benedini G; Cicogna R; Petroboni V; Riva S; Rusconi C; Orlando G
    G Ital Cardiol; 1976; 6(2):279-89. PubMed ID: 1010179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of the efficacy of sotalol and nadolol in the suppression of ventricular ectopic beats.
    Myburgh DP; Smith R; Diamond TH; Faitelson HL; Sommers DK
    S Afr Med J; 1983 Feb; 63(8):263-5. PubMed ID: 6337412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiac arrhythmias in recently diagnosed hypertensive patients at first presentation: an electrocardiographic-based study.
    Ejim EC; Ike SO; Anisiuba BC; Essien IO; Onwubere BJ; Ikeh VO
    Niger J Med; 2012; 21(1):6-10. PubMed ID: 23301439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapeutic indications for sotalol 160 mg].
    Ginestes J
    Ann Cardiol Angeiol (Paris); 1985 Jan; 34(1):45-52. PubMed ID: 2579609
    [No Abstract]   [Full Text] [Related]  

  • 52. Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.
    Anderson JL; Askins JC; Gilbert EM; Miller RH; Keefe DL; Somberg JC; Freedman RA; Haft LR; Mason JW; Lessem JN
    J Am Coll Cardiol; 1986 Oct; 8(4):752-62. PubMed ID: 2428852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ventricular arrhythmia in moderate essential arterial hypertension. Review of the literature apropos of 2 cases].
    Roul G; Bareiss P; Kieny JR; Fass H; Sachs D; Rochoux G; Stephan D; Mossard JM; Sacrez A
    Ann Cardiol Angeiol (Paris); 1990 Mar; 39(3):181-5. PubMed ID: 2140494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sotalol: a new beta-adrenergic blocker for ventricular arrhythmias.
    Cavusoglu E; Frishman WH
    Prog Cardiovasc Dis; 1995; 37(6):423-40. PubMed ID: 7777671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and adverse effects of sotalol in adults with congenital heart disease.
    Moore BM; Cordina RL; McGuire MA; Celermajer DS
    Int J Cardiol; 2019 Jan; 274():74-79. PubMed ID: 29954667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short- and long-term antiarrhythmic and hemodynamic effects of d,l-sotalol in patients with symptomatic ventricular arrhythmias.
    Hohnloser SH; Zabel M; Krause T; Just H
    Am Heart J; 1992 May; 123(5):1220-4. PubMed ID: 1575137
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppressant effects of conventional beta blockers and sotalol on complex and repetitive ventricular premature complexes.
    Deedwania PC
    Am J Cardiol; 1990 Jan; 65(2):43A-50A; discussion 51A-52A. PubMed ID: 1688482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of intravenous sotalol on ventricular arrhythmias occurring during maximal exercise stress testing.
    Stroobandt R; Kesteloot H
    Arch Int Pharmacodyn Ther; 1983 Aug; 264(2):290-7. PubMed ID: 6639220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness of oral sotalol for treatment of pediatric arrhythmias.
    Maragnès P; Tipple M; Fournier A
    Am J Cardiol; 1992 Mar; 69(8):751-4. PubMed ID: 1546649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy.
    Tendera M; Wycisk A; Schneeweiss A; Poloński L; Wodniecki J
    Cardiology; 1993; 82(5):335-42. PubMed ID: 8374931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.